Boisteau E, Lespagnol A, De Tayrac M, Corre S, et al. MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer. Clin Res Hepatol Gastroenterol 2022 Feb 18:101888.
PMID: 35189426